October 4, 2024
English ¿Qué es la semaglutida? La semaglutida pertenece a una clase de medicamentos conocidos como agonistas de los receptores del péptido-1 similar al glucagón (GLP-1). Imita […]
October 4, 2024
On This Page Date: November 12, 2024 Time: 11:00 AM – 12:00 PM ET Visit CDER Small Business and Industry Assistance Page ABOUT THIS EVENT (Hosted […]
October 4, 2024
ORLANDO — It’s important for pediatricians not only to understand the causes and effects of climate change but also to know how to discuss this issue […]
October 4, 2024
TOPLINE: Patients with inflammatory rheumatic diseases who are systematically screened for common chronic and preventable diseases are more likely to receive preventive medications and less likely […]
October 4, 2024
Palliative care has proven to be one of the most promising fields for research on interventions with psychedelic substances. One of the most prominent researchers in […]
October 4, 2024
When Kimberly Fisher, MD, was a junior doctor, she got fired up when patients showed hesitancy about vaccines. She responded by providing numbers, data, and facts […]
October 4, 2024
WASHINGTON — MRI-guided stereotactic body radiotherapy (SBRT) showed sustained benefits over CT-guided SBRT for prostate cancer, in a study. Amar Kishan, MD, of UCLA Health, presented […]
October 4, 2024
TOPLINE: Erenumab, injected monthly at 140 mg, can effectively induce remission of nonopioid medication overuse headache (MOH) in patients with chronic migraine within 6 months. The […]
October 4, 2024
TOPLINE: Prehospital opioid overdoses among young people increased sharply during the COVID-19 pandemic, with 86.7% cases occurring in young adults aged 18-24 years, a new study […]